Results 201 to 210 of about 6,805,202 (337)

Protective efficacy of six recombinant proteins as vaccine candidates against Echinococcus granulosus in dogs. [PDF]

open access: yesPLoS Negl Trop Dis, 2023
Shao G   +8 more
europepmc   +1 more source

FXa‐Responsive Hydrogels to Craft Corneal Endothelial Lamellae

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 10, April 15, 2025.
This study introduces a sacrificial, multicomponent biohybrid hydrogel system enabling stable scaffold‐free tissue engineering. Its efficacy is demonstrated through the ex vivo development, detachment, and transplantation of human corneal endothelial lamellae, achieving clinically relevant sizes for Descemet Membrane Endothelial Keratoplasty.
Mikhail V. Tsurkan   +7 more
wiley   +1 more source

Incorporation of recombinant proteins into extracellular vesicles by Lactococcus cremoris. [PDF]

open access: yesSci Rep
Plavec TV   +5 more
europepmc   +1 more source

Bioprinted Micro‐Clots for Kinetic Analysis of Endothelial Cell‐Mediated Fibrinolysis

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
This paper describes the development of a microscale model that quantifies the breakdown of fibrin by endothelial cells. The small size scale of this engineered system enables fibrin breakdown to be observed without the addition of external activators. This system could help in identifying compounds which both promote and hinder thrombosis.
Jonathan J. Chang   +5 more
wiley   +1 more source

Overview of the Purification of Recombinant Proteins

open access: yesCurrent Protocols in Protein Science, 2015
P. Wingfield
semanticscholar   +1 more source

Novel Less Toxic, Lymphoid Tissue‐Targeted Lipid Nanoparticles Containing a Vitamin B5‐Derived Ionizable Lipid for mRNA Vaccine Delivery

open access: yesAdvanced Healthcare Materials, Volume 14, Issue 7, March 14, 2025.
The top‐performing lipid nanoparticle, incorporating a novel ionizable lipid derived from vitamin B5, demonstrates high mRNA transfection efficiency, low toxicity, favorable stability, targeted delivery to lymphoid tissues, and high immunogenicity, showing promise as a carrier for mRNA vaccines for infectious diseases and cancer.
Soyeon Yoo   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy